1,264
Views
2
CrossRef citations to date
0
Altmetric
Articles

Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting

ORCID Icon, , , , , & show all
Pages 3178-3187 | Received 28 Apr 2022, Accepted 19 Jul 2022, Published online: 05 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tamara W. van Hal, Juul M. P. A. van den Reek, Mark H. Wenink, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Annet Oostveen, Bas Peters, Milan Tjioe, Else N. Kop, John E. M. Körver, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Maartje A. M. Berends, Wendelien R. Veldkamp, Martijn B. A. van Doorn, Johannes M. Mommers, Robert-Jan Lindhout, Astrid L. A. Kuijpers, Paula P. van Lümig, C. (Els) J. de Jonge, Ron A. Tupker, Judith Hendricksen, Romy R. Keijsers, Frank H. J. van den Hoogen, Johanna E. Vriezekolk & Elke M. G. J. de Jong. (2024) Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry. Journal of Dermatological Treatment 35:1.
Read now

Articles from other publishers (1)

Ibrahim A. Al-Homood, Mohammed Alajlan, Majid Alberdisi, Mohammad Alturki, Ahmed Ali Ahmed & Nancy Zakaria. (2024) Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting. Advances in Rheumatology 64:1.
Crossref